Tiling R - Search Results

1

Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT.

Hartenbach M, Weber S, Albert NL, Hartenbach S, Hirtl A, Zacherl MJ, Paprottka PM, Tiling R, Bartenstein P, Hacker M, Haug AR. Hartenbach M, et al. Among authors: tiling r. J Nucl Med. 2015 Nov;56(11):1661-6. doi: 10.2967/jnumed.115.158758. Epub 2015 Sep 24. J Nucl Med. 2015. PMID: 26405170 Free article.

2

Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.

Tiling R, Sommer H, Pechmann M, Moser R, Kress K, Pfluger T, Tatsch K, Hahn K. Tiling R, et al. J Nucl Med. 1997 Jan;38(1):58-62. J Nucl Med. 1997. PMID: 8998151 Free article.

3

Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.

Tiling R, Tatsch K, Sommer H, Meyer G, Pechmann M, Gebauer K, Münzing W, Linke R, Khalkhali I, Hahn K. Tiling R, et al. J Nucl Med. 1998 May;39(5):849-56. J Nucl Med. 1998. PMID: 9591588 Free article.

4

Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.

Moog F, Linke R, Manthey N, Tiling R, Knesewitsch P, Tatsch K, Hahn K. Moog F, et al. Among authors: tiling r. J Nucl Med. 2000 Dec;41(12):1989-95. J Nucl Med. 2000. PMID: 11138683 Free article.

5

18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.

Tiling R, Linke R, Untch M, Richter A, Fieber S, Brinkbäumer K, Tatsch K, Hahn K. Tiling R, et al. Eur J Nucl Med. 2001 Jun;28(6):711-20. doi: 10.1007/s002590100539. Eur J Nucl Med. 2001. PMID: 11440031 Clinical Trial.

6

Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses.

Tiling R, Stephan K, Sommer H, Shabani N, Linke R, Hahn K. Tiling R, et al. J Nucl Med. 2004 Nov;45(11):1822-8. J Nucl Med. 2004. PMID: 15534050 Free article. Clinical Trial.

7

Dobutamine myocardial scintigraphy for the prediction of cardiac events after heart transplantation.

Hacker M, Tausig A, Romüller B, Hoyer X, Klauss V, Stempfle U, Reichart B, Hahn K, Tiling R. Hacker M, et al. Among authors: tiling r. Nucl Med Commun. 2005 Jul;26(7):607-12. doi: 10.1097/01.mnm.0000167908.30977.fe. Nucl Med Commun. 2005. PMID: 15942481 Clinical Trial.

8

Comparison of spiral multidetector CT angiography and myocardial perfusion imaging in the noninvasive detection of functionally relevant coronary artery lesions: first clinical experiences.

Hacker M, Jakobs T, Matthiesen F, Vollmar C, Nikolaou K, Becker C, Knez A, Pfluger T, Reiser M, Hahn K, Tiling R. Hacker M, et al. Among authors: tiling r. J Nucl Med. 2005 Aug;46(8):1294-300. J Nucl Med. 2005. PMID: 16085585 Free article. Clinical Trial.

9

18F-FDG PET/CT for staging of penile cancer.

Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S. Scher B, et al. Among authors: tiling r. J Nucl Med. 2005 Sep;46(9):1460-5. J Nucl Med. 2005. PMID: 16157528 Free article. Clinical Trial.

10

Clinical validation of the gated blood pool SPECT QBS processing software in congestive heart failure patients: correlation with MUGA, first-pass RNV and 2D-echocardiography.

Hacker M, Hoyer X, Kupzyk S, La Fougere C, Kois J, Stempfle HU, Tiling R, Hahn K, Störk S. Hacker M, et al. Among authors: tiling r. Int J Cardiovasc Imaging. 2006 Jun-Aug;22(3-4):407-16. doi: 10.1007/s10554-005-9031-1. Epub 2005 Nov 22. Int J Cardiovasc Imaging. 2006. PMID: 16328851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters